Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058142
Filing Date
2025-04-24
Accepted
2025-04-24 16:44:27
Documents
22
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A iron-20250424.htm   iXBRL DEF 14A 2205855
2 GRAPHIC img85104428_0.jpg GRAPHIC 27875
3 GRAPHIC img85104428_1.jpg GRAPHIC 27875
4 GRAPHIC img85104428_2.jpg GRAPHIC 46918
5 GRAPHIC img85104428_3.jpg GRAPHIC 29760
6 GRAPHIC img85104428_4.jpg GRAPHIC 54096
7 GRAPHIC img85104428_5.jpg GRAPHIC 54914
8 GRAPHIC img85104428_6.jpg GRAPHIC 41209
9 GRAPHIC img85104428_7.jpg GRAPHIC 140852
10 GRAPHIC img85104428_8.jpg GRAPHIC 117780
  Complete submission text file 0000950170-25-058142.txt   4488993

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20250424.xsd EX-101.SCH 11700
24 EXTRACTED XBRL INSTANCE DOCUMENT iron-20250424_htm.xml XML 312672
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39438 | Film No.: 25868261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)